Mankind's Generic Nebivolol Hydrochloride Receives Approval in the U.S.
Prinston's Generic Nebivolol HCL, Valsartan Receives Approval in the U.S.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced business highlights and financial results for the three and six months ended June 30, 2022.
PRINSTON 's Generic Nebivolol Hydrochloride Receives Approval in US
Unichem's Generic Nebivolol Hydrochloride Receives Approval in the U.S.
AbbVie and a slate of generic drugmakers won a reprieve against claims they conspired to stall generics of the blood pressure med Bystolic in the U.S. A federal judge in New York tentatively scrapped two antitrust cases: one concerning direct purchasers like CVS and Walgreens and another with end payers as the plaintiffs. The drugmaker defendants were accused of delaying the market entry of copycats of the hypertension blockbuster, which AbbVie snagged by way of its $63 billion megamerger with Allergan.
Reyoung`s Generic Nebivolol Hydrochloride Receives Approval in the U.S.
Aurobindo Pharma`s Generic Nebivolol Hydrochloride Receives Approval in the U.S.
Cadila Pharms` Generic Nebivolol Hydrochloride Receives Approval in the U.S.
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.